
Applied Clinical Trials
The uncertainty surrounding where the agency and its 890-member staff will call home next may linger for months, if not years.

Applied Clinical Trials
The uncertainty surrounding where the agency and its 890-member staff will call home next may linger for months, if not years.

Applied Clinical Trials
Janssen releases key findings from its pilot study evaluating the use of electronic informed consent technology in clinical trials.

Applied Clinical Trials
More precision models in connecting patients to clinical trials and treatment options are vying to close the ever-elusive recruitment gap.

Applied Clinical Trials
Survey delves deep into what constitutes true game-changing innovation in clinical development.

Applied Clinical Trials
A proposed operational framework to support digital- and mHealth-based clinical trials in Africa.

Applied Clinical Trials
Exploring the benefits from cross-company data sharing for study planning and investigator selection.

Applied Clinical Trials
An examination of recent failures in Phase III studies and innovative approaches to reduce risk.

Applied Clinical Trials
Research reveals a need for sponsors to be much more consistent, disciplined and focused in their CRO usage.

Applied Clinical Trials
Study measures the differing judgment levels between clinical investigators and drug safety experts.







Applied Clinical Trials
Click the title above to open the Applied Clinical Trials August/September 2016 issue in an interactive PDF format.

Applied Clinical Trials
Start-up biotech selects Medidata Rave for Phase I and II trials of its investigational compound to address solid tumors and blood cancers.



INC Research announces the launch of its Vaccine Catalyst Site Network.


INC Research has achieved the “Bronze Standard” from the IAOCR’s Clinical Operations Workforce Quality Accreditation program.


ProTrials Research, Inc. and Calithera Biosciences have reached an agreement for early phase clinical trial support.


Bioclinica announces the acquisition of Orlando, Florida based Compass Research.

The drug development process has been seen as inefficient and disappointing by those in the R&D space. Model and Simulation provides a potential relief to these issues by delivering significant business, scientific and clinical value to drug developers.

The European Medicines Agency is proposing changes to the current guidelines on first-on-human clinical trials to improve risk-based strategies.
